- CATEGORY SARS-CoV-2 POC
- CATEGORY Clinical diagnostics kit
- CATEGORY EBT 102_48
- CATEGORY 48
- CATEGORY Disponibile
SARS-CoV-2 is a new strain of coronavirus, belonging to the Betacoronavirus family and first identified in humans in Whuan, China, in December 2019. This virus is highly transmitted and presents with severe symptoms only on one in five patients.
It is therefore extremely important to carry out a rapid and reliable diagnosis both in subjects presenting mild symptoms and in those presenting acute symptoms in order to direct them directly to the “CoViD-19” centers.
The Enbiotech kit allows to perform a rapid and specific qualitative test of SARS-CoV-2 in clinical swabs using a “Point of care” system and allowing to perform up to 12 tests simultaneously. The kit was tested for the detection of two gene markers. *.
* ISS COVID-19 Report No. 17/2020 ** Patent licenses WO 00/28082, WO 01/34790, WO 01/77317, WO 02/24902, WO 01/34838 *** Patent for industrial invention No. 0001425753 dated 09.11.2016 ****Process for obtaining the CE IVD mark has been initiated.
The kit comprises
Automatic interpretation of results
He system allows automatic interpretation of results, real-time display and online availability. Dark sigmoids at positive (+) samples indicate the presence of SARS-CoV-2s. The srette indicate that the analyzed samples are negative (or) for SARS-CoV-2s.